胞外超氧化物歧化酶(SOD3)活性蛋白
Active Superoxide Dismutase 3, Extracellular (SOD3)
SOD-3; EC-SOD; Extracellular Superoxide Dismutase Cu-Zn
- 編號(hào)APA117Hu03
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)6.8
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1193 ¥ 2982 ¥ 5964 ¥ 17892 ¥ 44730
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
Extracellular superoxide dismutase [Cu-Zn] is an enzyme that in humans is encoded by the SOD3 gene. This gene encodes a member of the superoxide dismutase (SOD) protein family. SODs are antioxidant enzymes that catalyze the dismutation of two superoxide radicals into hydrogen peroxide and oxygen. Acroding to the report, in a weakly alkaline buffer solution (pH=8.2) with N-tris(hydroxymethyl)amino methane-HCL, pyrogallol can occur autoxidation in the air, then SOD can inhibit this reaction. Thus, we use this way to measued the activity of recombinant human SOD3. The reaction was performed in adding 8 μl 5 mmol/L pyrogallol to 200 μl 50mmol/L Tris-HCl, rapidly mixing at 25 ℃, then read at 325 nm (using 50mmol/L Tris-HCl as blank control) in kinetic mode for 3 minutes using a microplate reader controlling the pyrogallol autoxidation rate at 0.70 OD/min. Different concentrations of recombinant human SOD3 were added into 200 μl 50 mmol/L Tris-HCl, incubated for 20 min at 25 ℃, then adding 8 μl 5 mmol/L pyrogallol to each well, rapidly mixing and read at 325 nm in kinetic mode for 3 minutes. Under these conditions, the enzyme amount of 50% inhibition of pyrogallol autooxidation per minute is defined as a unit. The specific activity of recombinant human SOD3 is 63.9 U/mg.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA117Hu01 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
APA117Hu62 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
APA117Hu03 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
APA117Hu04 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA117Hu01 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA117Hu61 | 胞外超氧化物歧化酶(SOD3)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA117Hu02 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA117Hu03 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA117Hu04 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA117Hu61 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA117Hu01 | 胞外超氧化物歧化酶(SOD3)多克隆抗體 | WB; IHC; ICC; IP. |
LAA117Hu71 | 胞外超氧化物歧化酶(SOD3)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA117Hu23 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA117Hu24 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | IHC |
MAA117Hu25 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA117Hu22 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB |
MAA117Hu21 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA117Hu27 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
SEA117Hu | 胞外超氧化物歧化酶(SOD3)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA117Hu | 胞外超氧化物歧化酶(SOD3)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Current Alzheimer Research | Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients. [pubmed:27748187] |
Frontiers in Microbiology | Burn Serum Increases Staphylococcus aureus Biofilm Formation via Oxidative Stress. [pubmed:28702016] |
Nature?Communications | SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α [Pubmed:29422508] |
BMC?Neuroscience | Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation [Pubmed:29523072] |
Diabetes-Metabolism?Research?and Reviews | Myeloperoxidase, superoxide dismutase‐3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study [Pubmed:29577557] |
Advances in Medical Sciences | Selected elements of extracellular matrix of the skin in diabetes and insulin resistance [Pubmed: 31146169] |
Clinical Kidney Journal | Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study [] |
PLoS One | Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study [Pubmed:34990470] |
ORIGINAL RESEARCH PATHOPHYSIOLOGY | EFFECTS OF HIS-PHE-ARG-TRP-PRO-GLY-PRO PEPTIDE ON FREE-RADICAL OXIDATION PROCESSES IN CONDITIONS OF CHRONIC RESTRAINT?… [] |